Evidence map›Paper›PMID 26320937›Full record

ArticleJournal of extracellular vesicles2015

Meeting report: discussions and preliminary findings on extracellular RNA measurement methods from laboratories in the NIH Extracellular RNA Communication Consortium.

Louise C Laurent, Asim B Abdel-Mageed, P David Adelson, Jorge Arango, Leonora Balaj, Xandra Breakefield, Elizabeth Carlson, Bob S Carter, Blanca Majem, Clark C Chen and 40 more

Abstract read
In one paragraph

Article in Journal of extracellular vesicles, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed.

  1. Expression pattern of circulating long non-coding RNAArchives of medical science : AMS · 2026
    Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Progress of Exosomal LncRNAs in Pancreatic Cancer.International journal of molecular sciences · 2024
    Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Extracellular RNAs as potential biomarkers for cancer.Journal of cancer metastasis and treatment · 2020
    Article
  17. Review
  18. Article
  19. Article
  20. Emerging role of extracellular vesicles in the regulation of skeletal muscle adaptation.Journal of applied physiology (Bethesda, Md. : 1985) · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

50 authors.

Louise C LaurentDivision of Maternal Fetal Medicine, Department of Reproductive Medicine, University of California San Diego, San Diego, CA, USA.
Asim B Abdel-MageedDepartment of Urology, Tulane University, School of Medicine, New Orleans, LA, USA.
P David AdelsonPhoenix Children's Hospital, Phoenix, AZ, USA.
Jorge ArangoPhoenix Children's Hospital, Phoenix, AZ, USA.
Leonora BalajDepartment of Neurology, Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA.
Xandra BreakefieldDepartment of Neurology, Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA.
Elizabeth CarlsonNeurogenomics Division, Translational Genomics Research Institute, Phoenix, AZ, USA.
Bob S CarterCenter for Theoretical and Applied Neuro-Oncology, Division of Neurosurgery, University of California San Diego, San Diego, CA, USA.
Blanca MajemSchool of Dentistry, University of California, Los Angeles, CA, USA.
Clark C ChenCenter for Theoretical and Applied Neuro-Oncology, Division of Neurosurgery, University of California San Diego, San Diego, CA, USA.
Emanuele CocucciProgram in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA, USA.
Kirsty DanielsonCardiovascular Institute, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Amanda CourtrightNeurogenomics Division, Translational Genomics Research Institute, Phoenix, AZ, USA.
Saumya DasCardiovascular Institute, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Zakaria Y Abd ElmageedDepartment of Urology, Tulane University, School of Medicine, New Orleans, LA, USA.
Daniel EnderleExosome Diagnostics GmbH, Martinsried, Germany.
Alan EzrinNXPharmaGen, Miami, FL, USA.
Marc FerrerDivision of Preclinical Innovation, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health, Bethesda, MD, USA.
Jane FreedmanDepartment of Medicine, University of Massachusetts Medical School, Worcester, MA, USA.
David GalasPacific Northwest Diabetes Research Institute, Seattle, WA, USA.
Roopali GandhiDepartment of Neurology, Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Matthew J HuentelmanTGen, Phoenix, AZ, USA.
Kendall Van Keuren-JensenNeurogenomics Division, Translational Genomics Research Institute, Phoenix, AZ, USA.
Yashar KalaniBarrow Neurological Institute, Phoenix, AZ, USA.
Yong KimSchool of Dentistry, University of California, Los Angeles, CA, USA.
Anna M KrichevskyDepartment of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Charles LaiDepartment of Neurology, Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA.
Madhu Lal-NagDivision of Preclinical Innovation, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health, Bethesda, MD, USA.
Clara D LaurentCardiovascular Institute, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Trevor LeonardoCardiovascular Institute, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Feng LiSchool of Dentistry, University of California, Los Angeles, CA, USA.
Ivana MalenicaNeurogenomics Division, Translational Genomics Research Institute, Phoenix, AZ, USA.
Debasis MondalDepartment of Pharmacology, Tulane University School of Medicine, New Orleans, LA, USA.
Parham NejadDepartment of Neurology, Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Tushar PatelDepartment of Transplantation, Mayo Clinic Florida, Jacksonville, FL, USA.
Robert L RaffaiDepartment of Surgery, University of California San Francisco, San Francisco, CA, USA.
Renee RubioCenter for Cancer Computational Biology, Dana Farber Cancer Institute, Boston, MA, USA.
Johan SkogExosome Diagnostics, Cambridge, MA, USA.
Robert SpetzlerBarrow Neurological Institute, Phoenix, AZ, USA.
Jie SunSchool of Dentistry, University of California, Los Angeles, CA, USA.
Kahraman TanriverdiDepartment of Medicine, University of Massachusetts Medical School, Worcester, MA, USA.
Kasey VickersDepartment of Molecular Physiology and Biophysics, Vanderbilt University Medical Center, Nashville, TN, USA.
Liang WangDepartment of Pathology, Medical College of Wisconsin, Milwaukee, WI, USA.
Yaoyu WangCenter for Cancer Computational Biology, Dana Farber Cancer Institute, Boston, MA, USA.
Zhiyun WeiDepartment of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Howard L WeinerDepartment of Neurology, Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
David WongSchool of Dentistry, University of California, Los Angeles, CA, USA.
Irene K YanDepartment of Cancer Biology, Mayo Clinic Florida, Jacksonville, FL, USA.
Ashish YeriNeurogenomics Division, Translational Genomics Research Institute, Phoenix, AZ, USA.
Stephen GouldDepartment of Biological Chemistry, Johns Hopkins University, Baltimore, MD, USA.

Funding

The role of microvesicles in giloma virotherapyP01CA069246 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI CHAREST, ALAIN · 1996 to 2021
$30.9M
Non-coding RNA & Bioinformatics CoreP01HL116263 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI DAVIES, SEAN STEPHEN · 2014 to 2025
$24.7M
SOC CoreU54DA036134 · NIDA · BAYLOR COLLEGE OF MEDICINE · PI GALAS, DAVID J., GERSTEIN, MARK BENDER · 2013 to 2018
$15.0M
Transfer of microRNA regulators from glioblastoma to brain microenvironment U19CA179563 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI BREAKEFIELD, XANDRA OWENS, CHAREST, ALAIN · 2013 to 2017
$8.6M
Transcellular epigenetic regulation by ex-small RNA in C. elegantU19CA179512 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BLELLOCH, ROBERT · 2013 to 2017
$7.4M
Trafficking of eRNAs in K-Ras Mutant Colon CancerU19CA179514 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI COFFEY, ROBERT J. · 2013 to 2017
$5.3M
Reference Profiles of Extracellular RNA in 4 Body Fluids of Healthy HumansU01HL126496 · NHLBI · PACIFIC NORTHWEST RESEARCH INSTITUTE · PI GALAS, DAVID J., NICKERSON, DEBORAH A · 2014 to 2018
$3.5M
Reference Profiles of ExRNAs in Normal Human PregnancyU01HL126494 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI LAURENT, LOUISE CHANG · 2014 to 2018
$3.4M
Plasma miRNA predictors of adverse mechanical and electrical remodeling after MIUH3TR000901 · NCATS · MASSACHUSETTS GENERAL HOSPITAL · PI DAS, SAUMYA, KWONG, RAYMOND Y · 2015 to 2017
$3.2M
exRNA Biomarkers for Human GliomaUH3TR000931 · NCATS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CARTER, BOB S, HOCHBERG, FRED H · 2015 to 2017
$3.0M
Extracellular non-coding RNA biomarkers of hepatocellular cancerUH3TR000884 · NCATS · MAYO CLINIC JACKSONVILLE · PI PATEL, TUSHAR · 2015 to 2017
$3.0M
Clinical Utility of Salivary ExRNA Biomarkers for Gastric Cancer DetectionUH3TR000923 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI WONG, DAVID T · 2015 to 2017
$2.7M
NCATS NIH HHS UH2 TR000884NCATS NIH HHS UH2 TR000890NCATS NIH HHS UH2 TR000891NCATS NIH HHS UH2 TR000901NCATS NIH HHS UH2 TR000906NCATS NIH HHS UH2 TR000921NCATS NIH HHS UH2 TR000923NCATS NIH HHS UH2 TR000928NCATS NIH HHS UH2 TR000931NCATS NIH HHS UH3 TR000884NCATS NIH HHS UH3 TR000890NCATS NIH HHS UH3 TR000901NCATS NIH HHS UH3 TR000923NCATS NIH HHS UH3 TR000928NCATS NIH HHS UH3 TR000931NCI NIH HHS P01 CA069246NCI NIH HHS U19 CA179512NCI NIH HHS U19 CA179514NCI NIH HHS U19 CA179563NHLBI NIH HHS P01 HL116263NHLBI NIH HHS R01 HL128996NHLBI NIH HHS U01 HL126494NHLBI NIH HHS U01 HL126496NIDA NIH HHS U54 DA036134
6 · The paper itself

Abstract

Extracellular RNAs (exRNAs) have been identified in all tested biofluids and have been associated with a variety of extracellular vesicles, ribonucleoprotein complexes and lipoprotein complexes. Much of the interest in exRNAs lies in the fact that they may serve as signalling molecules between cells, their potential to serve as biomarkers for prediction and diagnosis of disease and the possibility that exRNAs or the extracellular particles that carry them might be used for therapeutic purposes. Among the most significant bottlenecks to progress in this field is the lack of robust and standardized methods for collection and processing of biofluids, separation of different types of exRNA-containing particles and isolation and analysis of exRNAs. The Sample and Assay Standards Working Group of the Extracellular RNA Communication Consortium is a group of laboratories funded by the U.S. National Institutes of Health to develop such methods. In our first joint endeavour, we held a series of conference calls and in-person meetings to survey the methods used among our members, placed them in the context of the current literature and used our findings to identify areas in which the identification of robust methodologies would promote rapid advancements in the exRNA field.

Indexed as

exosomesextracellular RNAextracellular vesiclesmicrovesiclesRNA sequencing

Identifiers

PMID26320937
PMCPMC4553263

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.